Compare Enveric Biosciences Inc (ENVB) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Consumer Staples Select Sector SPDR Fund — how do they compare? Enveric Biosciences Inc trades at $1.37 (market cap $5.32M), while Consumer Staples Select Sector SPDR Fund trades at $85.67. The key difference: Consumer Staples Select Sector SPDR Fund is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | XLP | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | — |
52-Week High | $17.40 | $90.00 |
52-Week Low | $1.28 | $75.61 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
XLP trades at $85.51, up 2.52% with a bullish analyst consensus of 100% buy ratings. Technical indicators show bearish momentum despite the recent gain, with resistance at $85. The ETF's 2.6% dividend yield provides income appeal amid market volatility, though key valuation ratios remain unavailable for detailed fundamental assessment.
The defensive consumer staples sector positioning offers stability during economic uncertainty, but technical weakness and concentrated holdings present near-term risks. Long-term prospects depend on sector performance and expense ratio competitiveness against peers like VDC.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
